¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"path analysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® semen analysis ÇÑ±Û Á¤¾× °Ë»ç
¼³¸í   
  ºÎºÎ¿¡°Ô¼­ ÀÓ½ÅÀÌ ¾ÈµÇ´Â °æ¿ì ½Ç½ÃÇϴ ºÒÀÓ °Ë»çÁßÀÇ Çϳª·Î Á¤¾×ÀÇ ¾ç, Á¤ÀÚÀÇ ¿îµ¿¼º, ¸ð¾ç, ¼ö µîÀ» ÃøÁ¤ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path analysis
    °æ·ÎºÐ¼®
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • association path
    ¿¬ÇÕµµ
  • condyle path
    °üÀýÀ¶±â·Î
  • incisor path
    ¾Õ´Ï±æ, ÀýÄ¡·Î
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î
  • path
    °æ·Î, Åë·Î
  • antigen analysis
    Ç׿øºÐ¼®
  • arterial blood gas analysis
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • analysis
    ºÐ¼®
  • birth cohort analysis
    Ãâ»ýÄÚȣƮºÐ¼®
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clonal analysis
    Ŭ·ÐºÐ¼®
  • cluster analysis
    ¹«¸®ºÐ¼®
  • cohort analysis
    ÄÚȣƮºÐ¼®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path analysis
    °æ·ÎºÐ¼®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path
    °æ·Î, Åë·Î
  • analysis
    ºÐ¼®
  • antigen analysis
    Ç׿øºÐ¼®
  • qualitative analysis
    Á¤¼ººÐ¼®
  • quantitative analysis
    Á¤·®ºÐ¼®
  • statistical analysis
    Åë°èºÐ¼®
  • survival analysis
    »ýÁ¸ºÐ¼®
  • system analysis
    °èÅëºÐ¼®
  • meta-analysis
    ¸ÞŸºÐ¼®
  • self-analysis
    ÀÚ±âºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path analysis
    °æ·ÎºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • association path
    ¿¬ÇÕµµ
  • condyle path
    °üÀýÀ¶±â·Î
  • incisor path
    ¾Õ´Ï±æ, ÀýÄ¡·Î
  • path
    °æ·Î, Åë·Î
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î
  • analysis
    ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • antigen analysis
    Ç׿øºÐ¼®
  • birth cohort analysis
    Ãâ»ýÄÚȣƮºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
  • clinical decision analysis
    ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
  • clonal analysis
    Ŭ·ÐºÐ¼®
  • cluster analysis
    ¹«¸®ºÐ¼®
  • cohort analysis
    ÄÚȣƮºÐ¼®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Final common path
    ÃÖÁ¾(õÌðû)°øÅë(Íì÷×)Åë·Î(÷×ÖØ)
  • artificial condyle path
    Àΰø °ú·Î(¡­Î¨ÖØ).
  • incisal path
    ÀýÄ¡·Î(ôîöÍÖØ).
  • incisor path recording apparatus
    Àý´Ü·Î¹¦»ç±â(ôîÓ®ÖØÙÚÞÐÐï).
  • inclination of condyle path
    °ú·Î°æ»çµµ(Î¨ÖØÌËÞØöô).
  • inclination of lateral condyle path
    Ãø¹æ°ú·Î°æ»ç(µµ)(ö°Û°Î¨ÖØÌËÞØöô).
  • inclination of sagittal incisal path
    ½Ã»óÀýÄ¡·Î°¢(ãÅßÒôîöÍÖØÊÇ).
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î(¡­ÌèÖØ).
  • DNA sequence analysis
    DNA ¼­¿­ºÐ¼®
  • Data analysis
    Á¤º¸ºÐ¼®
  • Decision analysis
    °áÁ¤ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • amniotic fluid analysis
    ¾ç¼öºÐ¼®
  • analysis
    ºÐ¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • artificial condyle path
    Àΰø °ú·Î(¡­Î¨ÖØ).
  • association path
    ¿¬ÇÕµµ.
  • average path
    Æò±ÕµµÁ¤(¡­Ô³ïï).
  • band path
    ´ëµµ(ÓáÔ³)
  • efferent path
    ¿ø½É°æ·Î(êÀãýÌèÖØ).
  • end path
    Á¾·Î(ðûÖØ).
  • incisal path
    ÀýÄ¡·Î(ôîöÍÖØ).
  • incisor path recording apparatus
    Àý´Ü·Î¹¦»ç±â(ôîÓ®ÖØÙÚÞÐÐï).
  • inclination of condyle path
    °ú·Î°æ»çµµ(Î¨ÖØÌËÞØöô).
  • inclination of lateral condyle path
    Ãø¹æ°ú·Î°æ»ç(µµ)(ö°Û°Î¨ÖØÌËÞØöô).
  • inclination of sagittal incisal path
    ½Ã»óÀýÄ¡·Î°¢(ãÅßÒôîöÍÖØÊÇ).
  • lateral condyle path
    ¿ÜÃø°ú·Î.
  • lateral incisal path
    Ãø¹æÀýÄ¡·Î(ö°Û°ôîöÍÖØ).
  • optical path
    ±¤·Î(ÎÃÖØ).
  • particle path
    ÀÔÀÚÅë·Î(í£í­÷×ÖØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • light path
    ±¤·Î(ÎÃÖØ)
  • mean free path
    Æò±ÕÀÚÀ¯°æ·Î(øÁгí»ë¦ÌèÖØ)
  • optical path
    ±¤Çà·Î(ÎÃú¼ÖØ)
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼® (üÀàõûùÝÂà°)
  • amino acid analysis
    ¾Æ¹Ì³ë»ê(ß«) ºÐ¼®(ÝÂà°)
  • analysis of variance
    ºÐ»êºÐ¼®(ÝÂߤÝÂà°)
  • conformational analysis
    ÀÔüÇüÅ ºÐ¼®(Ø¡ô÷û¡÷¾ÝÂà°)
  • control analysis
    ´ëÁ¶ ºÐ¼®(ÓßðÎÝÂà°)
  • covalent structure analysis
    °øÀ¯°áÇÕ ±¸Á¶ºÐ¼®(ÍìêóÌ¿ùêϰðãÝÂà°)
  • differential thermal analysis
    Â÷ ¿­ºÐ¼®(ó¬æðÝÂà°)
  • displacement analysis
    ´ëÄ¡ºÐ¼®(ÓÛöÇÝÂà°)
  • double isotope dilution analysis
    ÀÌÁß µ¿À§¿ø¼Ò Èñ¼®ºÐ¼®(ì£ñìÔÒêÈêªáÈýüà·ÝÂà°)
  • elementary analysis
    ¿ø¼Ò ºÐ¼® (êªáÈÝÂà°)
  • elution analysis
    ¿ë¸® ºÐ¼® (éÁ×îÝÂà°)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • path
    °æ·Î, Åë·Î, ÆÐ½º
  • analysis
    ºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
  • computerized image analysis
    ÄÄÇ»ÅÍ¿µ»óºÐ¼®
  • image analysis
    ¿µ»óºÐ¼®
  • in vitro analysis
    °ü³»ºÐ¼®
  • in vivo analysis
    »ýü³»ºÐ¼®
  • infrared spectroscopic analysis
    Àû¿Ü¼±ºÐ±¤ºÐ¼®
  • quantitative analysis
    Á¤·®ºÐ¼®
  • radiometric analysis
    ¹æ»ç¼±ºÐ¼®
  • sequential analysis
    ¼øÂ÷ÀûºÐ¼®
  • spectral analysis
    ½ºÆåÆ®·³ºÐ¼®
  • statistical analysis
    Åë°èÀûºÐ¼®
  • urine analysis
    ¿ä°Ë»ç
  • vector analysis
    ¹éÅͺм®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
EPL effective patient's life; equivalent path length; essential phospholipid; extensor pollicis longus; ...
OPD obstetric prediabetic; optical path difference; otopalatodigital [syndrome]; outpatient department; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MPP Medial perforant path
PP Perforant Path
LPP lateral perforant path
MANOVA 2-multivariate analysis of variance
ANOVA ANalysis Of VAriance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • artificial condyle path
    Àΰø °ú·Î
  • condylar path element
    °ú·ÎºÎ
  • efferent path
    ¿ø½É °æ·Î
  • end path
    Á¾·Î
  • functionally generated path
    ±â´É ¿îµ¿·Î
  • incisor path recording apparatus
    Àý´Ü·Î ¹¦»ç±â
    Gysi´Â ÇÏ¾Ç ¿îµ¿À» ±âÇÏÇÐÀûÀ¸·Î ¿¬±¸Çϱâ À§ÇÏ¿© ÇÏ¾Ç ÀüÄ¡ºÎÀÇ ¿îµ¿ ±ËÀûÀ» ±³ÇÕÆò¸é ¹× Á¤Á߸鿡 À־ ±â·ÏÇÏ´Â ÀåÄ¡¸¦ °í¾ÈÇß´Ù. ¹¦»ç±â´Â ÇÏ¾Ç ±³ÇÕÁ¦ Àü¸é¿¡ ÀåÄ¡µÈ´Ù. ¹¦±âħÀÇ Çϳª´Â ±³ÇÕ Æò¸é¿¡ À־ÀÇ ÀüÄ¡ºÎ Ãø¹æ ¿îµ¿ÀÇ ±ËÀûÀ» ±â·ÏÇϱâ À§ÇÏ¿© »ó¹æ ±³ÇÕÁ¦¿¡ ÇÏÇâÀ¸·Î, ´Ù¸¥ Çϳª´Â Á¤Áß¸é »óÀÇ °³Æó ¿îµ¿ ±ËÀûÀÌ ±â·ÏµÇ°Ô²û ¿·À¸·Î ÇâÇÏ¿© ÀåÄ¡µÇ¾î ÀÖ´Ù.
  • inclination of sagittal incisal path
    ½Ã»ó ÀýÄ¡·Î °¢
    1. ÇϾÇÀÇ ÀüÁø ¿îµ¿¿¡ À־, ÇÏ¾Ç ÀüÄ¡Á¡Àº ÀüÇϹæÀ¸·Î À̵¿Çؼ­ ½Ã»ó ÀüÄ¡·Î °¢À» ±×¸®´Âµ¥ ±× Á¦ 1»óÀÌ ±³ÇÕ Æò¸é°ú ÀÌ·ç´Â °¢À» ½Ã»ó ÀüÄ¡·Î °¢À̶ó°í ÇÑ´Ù. Gysi¿¡ ÀÇÇϸé 40?~80?, Nakasawa¿¡ ÀÇÇϸé 0?~62?, Æò±Õ 34?ÀÌ´Ù. ¹«Ä¡¾Ç¿¡¼­´Â °íÀ¯ÀÇ ¼öÄ¡°¡ ¾øÀ¸³ª, ±¸Ä¡ºÎ ±³µÎ°æ»ç¿Í Á¤ºñ·ÊÀûÀ¸·Î °ü°èµÇ¾î, ÀÇÄ¡ÀÇ ±â´É°ú °ü°è°¡ ±íÀ¸¹Ç·Î µµÄ¡ ¹è¿­ ½Ã¿¡ Àû´çÈ÷ Á¶Àý, ¼³Á¤ÇÑ´Ù. Æò±Õ½Ä±³±³±â¿¡¼­´Â 10?ÀÇ °ÍÀÌ ¸¹´Ù. 2. ÇϾÇÀÇ Ãø¹æ ¿îµ¿ ½Ã¿¡ ÀüÄ¡Á¡Àº Á¿ìÃøÀÇ Àü¿ÜÇϹæÀ¸·Î À̵¿ÇÏ¿© ¼ÒÀ§ °íµñ¾ÆÄ¡¸¦ ±×¸°´Ù. ÀÌ¿¡ ÀÇÇÏ¿© ¾ò¾îÁø °¢ÀÇ ±³ÇÕ Æò¸é¿¡ Åõ¿µÇÑ °¢À» Ãø¹æ ÀýÄ¡·Î °æ»çµµ¶ó°í Çϸç, Gysi¿¡ ÀÇÇÏ¿© Æò±Õ 120?¶ó°í ÇÑ´Ù. ±¸Ä¡ºÎÀÇ ±³µÎ °æ»ç¿Í ¿ªºñ·ÊÀûÀÎ °ü°è¸¦ ³ªÅ¸³½´Ù.
  • milled-in path
    ±â·Ï·Î, ¸¶¸ð ±³ÇÕ·Î, ÀÚµ¿ ¸¶¸ð ±³ÇÕ ¸¸°î
    ÇϾǰñÀÌ ¿îµ¿À» ÇÒ ¶§, »ó´ëµÇ´Â ±³ÇÕ ¸é¿¡´Â Ä¡¾Æ³ª ¾î¶² ÀåÄ¡°¡ µÇ¾î ÀÖ¾î À̰ÍÀÌ ±³ÇÕÁ¦ÀÇ ±³ÇÕ ¸é¿¡ ÀÚµ¿ÀûÀ¸·Î Á¶°¢µÇ¾î ³ªÅ¸³­ »óÅÂ.
  • occlusal path registration
    ±³ÇÕ·Î ±â·Ï
    ȯÀÚ ±¸°­ ³»¿¡¼­ ´ëÇÕÄ¡¿¡ ÀÇÇÏ¿© wax¿¡ ÀαâµÇ°Å³ª ±â·ÏµÈ ±³ÇÕ·ÎÀÇ ±â·Ï.
  • path
    °æ·Î, Åë·Î, ÆÐ½º
    Áö³ª°¡´Â ¶Ç´Â Ⱦ´ÜÇϴ Ư¼öÇÑ Åë·Î. ½Å°æÇп¡¼­´Â ±¸½É¼º, ¶Ç´Â ¿ø½É¼ºÀ¸·Î ½Å°æ Ãæµ¿À» Àü´ÞÇÏ´Â ½Å°æ ¼¶À¯ÀÇ ÇÑ °æ·Î·Î¼­, ƯÈ÷ ±× °æ·ÎÀÇ µÎ°³³» ¹× ô¼ö³» ºÎºÐÀ» ¸»ÇÑ´Ù.
  • path of insertion
    »ðÀÔ·Î
    º¸Ã¶¹°ÀÌ Áö´ëÄ¡ÀÇ Ã³À½ Á¢ÃËÁ¡À¸·ÎºÎÅÍ ±¹¼Ò ÀÇÄ¡ÀÇ ·¹½ºÆ®¿Í ÀÇÄ¡»óÀÌ Á¦ À§Ä¡¿¡ µé¾î°¡´Â ÃÖÁ¾ ¾ÈÁ¤ À§Ä¡±îÁö º¸Ã¶¹°ÀÌ ¿òÁ÷ÀÌ´Â ¹æÇâ.
  • path of placement
    »ðÀÔ·Î
  • ray path
    ±¤¼±·Î
  • rotating path
    ȸÀü °æ·Î
  • rotational path removable partial denture
    ȸÀü °æ·Î·Î ÀåÂøÇÏ´Â °¡Ã¶¼º ºÎºÐ»ó ÀÇÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
path analysis A mode of analysis involving assumptions about the direction of causal relationships among linked sequences and configurations of variables.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
generated occlusal path A registration of the path's of movement of the occlusal surfaces of mandibular teeth on a plastic or abrasive surface attached to the maxillary arch.
See: functional chew-in record.
(05 Mar 2000)
mean free path <radiobiology> Average distance a particle travels between occurrences of the given event, for example, between collisions. For collisions, the mean free path is roughly equal to unity divided by the product of the collision cross-section times the particle density.
(09 Oct 1997)
path A road or way; the course taken by an electric current or by nervous impulses.
See: pathway.
Origin: A.S. Paeth
(05 Mar 2000)
path function <chemistry> A property that is dependent on the path taken.
(09 Jan 1998)
path of insertion The direction in which a dental prosthesis is placed upon or removed from the supporting tissues or abutment teeth.
(05 Mar 2000)
condyle path The path traveled by the mandibular condyle in the temporomandibular joint during the various mandibular movements.
(05 Mar 2000)
incisal path The influence on mandibular movements caused by the contacting surfaces of the mandibular and maxillary anterior teeth during eccentric excursions.
Synonym: incisal path.
(05 Mar 2000)
occlusal path A gliding occlusal contact, the path of movement of an occlusal surface.
(05 Mar 2000)
accumulation analysis A technique in which an intermediate of a metabolic pathway accumulates due to selective inhibition of a particular step in that pathway or in a mutant that is deficient in a certain step. The intermediate is then isolated, analyzed, and identified.
(05 Mar 2000)
activation analysis <radiobiology> Method for identifying and measuring chemical elements in a sample of material. Sample is first made radioactive by bombardment with neutrons, charged particles, or gamma rays.
Newly formed radioactive atoms in the sample then give off characteristic radiations (such as gamma rays) that tell what kinds of atoms are present, and how many.
(09 Oct 1997)
actuarial analysis The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.
(12 Dec 1998)
amino acid analysis Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid.
(05 Mar 2000)
analysis <technique> The separation into component parts or elements, the act of determining the component parts of a substance.
Origin: Gr. Lysis = dissolution
(18 Nov 1997)
analysis of variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
(12 Dec 1998)
base sequence analysis <molecular biology> A method, sometimes automated, for determining the base sequence.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • critical path analysis (method)
    Å©¸®Æ¼Äà ÆÐ½º ºÐ¼®¹ý(ÇÁ·ÎÁ§Æ®ÀÇ °èȹ.°ü¸®¸¦ °úÇÐÀûÀ¸·Î ÇÏ´Â ¹æ¹ý)
  • by-path
    ¿·±æ
  • path
    ÀÛÀº ±æ,º¸µµ
  • bridle path
    ½Â¸¶±æ
  • cinder path
    ¼®Åº À縦 ±ò¾Æ ´ÙÁø º¸µµ;=CINDER TRACK
  • flare path
    (ºñÇàÀåÀÇ)Á¶¸íȰÁÖ·Î
  • flight path
    ºñÇà °æ·Î
  • glide path
    ±Û¶óÀÌµå ÆÐ½º;±Û¶óÀÌµå ½½·ÎÇÁ(ƯÈ÷ °è±â ºñÇà½Ã ¹«¼± ½ÅÈ£¿¡ ÀÇÇÑ È°°­ Áø·Î)
  • middle path
    Áßµµ
  • path
    ±æ;Åë·Î;Çà·Î
  • primrose path
    ȯ¶ôÀÇ ±æ;¹æÅÁ;³­ºÀ
  • analysis
    ºÐÇØ
  • analysis
    ºÐ¼®;ÇØ¼®;ºÐÇØ
  • conformational analysis
    ¹èÁÂ ÇØ¼®
  • content analysis
    ³»¿ë ºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á